Carlsmed, Inc. Common Stock (CARL) - Net Assets
Based on the latest financial reports, Carlsmed, Inc. Common Stock (CARL) has net assets worth $98.87 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($130.12 Million) and total liabilities ($31.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Carlsmed, Inc. Common Stock (CARL) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $98.87 Million |
| % of Total Assets | 75.98% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Carlsmed, Inc. Common Stock - Net Assets Trend (2023–2025)
This chart illustrates how Carlsmed, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore CARL total asset value for the complete picture of this company's asset base.
Annual Net Assets for Carlsmed, Inc. Common Stock (2023–2025)
The table below shows the annual net assets of Carlsmed, Inc. Common Stock from 2023 to 2025. For live valuation and market cap data, see Carlsmed, Inc. Common Stock market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $98.87 Million | +239.98% |
| 2024-12-31 | $-70.63 Million | -53.11% |
| 2023-12-31 | $-46.13 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Carlsmed, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5389100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $199.67 Million | 201.96% |
| Total Equity | $98.87 Million | 100.00% |
Carlsmed, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Carlsmed, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Smart Share Global Ltd ADR
NASDAQ:EM
|
$253.44 Million |
|
Com2uS Corporation
KQ:078340
|
$253.50 Million |
|
Panora Gayrimenkul Yatirim Ortakligi AS
IS:PAGYO
|
$253.51 Million |
|
Transportadora de Gas del Norte SA Class C
BA:TGNO4
|
$253.55 Million |
|
Honda India Power Products Limited
NSE:HONDAPOWER
|
$253.29 Million |
|
El-Mor Electric Installation & Services 1986 Ltd
TA:ELMR
|
$253.01 Million |
|
Atha Energy Corp.
V:SASK
|
$253.00 Million |
|
Berry Petroleum Corp
NASDAQ:BRY
|
$253.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Carlsmed, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -70,630,000 to 98,869,000, a change of 169,499,000.
- Net loss of 30,218,000 reduced equity.
- New share issuances of 105,384,000 increased equity.
- Other factors increased equity by 94,333,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-30.22 Million | -30.56% |
| Share Issuances | $105.38 Million | +106.59% |
| Other Changes | $94.33 Million | +95.41% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Carlsmed, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.36x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $-10.38 | $9.48 | x |
| 2024-12-31 | $-4.26 | $9.48 | x |
| 2025-12-31 | $6.95 | $9.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Carlsmed, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -30.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -59.82%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.32x
- Recent ROE (-30.56%) is below the historical average (-10.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | 0.00% | -137.16% | 0.98x | 0.00x | $-14.29 Million |
| 2024 | 0.00% | -89.30% | 0.52x | 0.00x | $-17.19 Million |
| 2025 | -30.56% | -59.82% | 0.39x | 1.32x | $-40.10 Million |
Industry Comparison
This section compares Carlsmed, Inc. Common Stock's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $564,497,981
- Average return on equity (ROE) among peers: -15.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Carlsmed, Inc. Common Stock (CARL) | $98.87 Million | 0.00% | 0.32x | $253.42 Million |
| Aclarion Inc (ACON) | $-5.73 Million | 0.00% | 0.00x | $1.99 Million |
| American Well Corp (AMWL) | $1.08 Billion | -24.95% | 0.12x | $90.87 Million |
| Heartbeam Inc (BEAT) | $63.68 Million | -15.38% | 0.96x | $30.37 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-3.06 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $1.65 Billion | -1.09% | 2.59x | $8.82 Billion |
| CareCloud Inc. (CCLD) | $118.50K | -150.21% | 47.72x | $117.28 Million |
| Certara Inc (CERT) | $492.77 Million | -6.75% | 1.13x | $983.48 Million |
| CareMax Inc (CMAX) | $6.73 Million | 88.33% | 4.72x | $381.50 |
| Claritev Corporation (CTEV) | $1.79 Billion | -32.00% | 3.12x | $277.75 Million |
About Carlsmed, Inc. Common Stock
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more